MZF1 and neoplasm: To further assess the therapeutic efficacy of lentivirus‐mediated MZF1‐AS1 knockdown on tumor progression in vivo, nude mice were treated with subcutaneous or tail vein injection of IMR‐32 cells stably expressing red fluorescent protein.